Addnode - Rebound in PLM

Redeye keeps its Base Case unchanged and makes minor estimate revisions following a Q2 report roughly matching our expectations. Overall, Addnode continues to deliver stable results, but a larger acquisition is needed to move the needle on our Base Case.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/